Amarin (AMRN) News Today → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free amrn Stock Alerts $0.88 +0.02 (+2.33%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conferenceglobenewswire.com - May 6 at 8:00 AMQ2 2025 EPS Estimates for Amarin Co. plc Lowered by Zacks Research (NASDAQ:AMRN)americanbankingnews.com - May 4 at 4:04 AMAmarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 3 at 8:34 PMQ2 2025 EPS Estimates for Amarin Co. plc (NASDAQ:AMRN) Reduced by Zacks Researchmarketbeat.com - May 3 at 11:37 AMAmarin (NASDAQ:AMRN) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPSmarketbeat.com - May 2 at 1:59 PMAmarin First Quarter 2024 Earnings: EPS Beats Expectationsfinance.yahoo.com - May 2 at 10:06 AMAmarin’s Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growthmarkets.businessinsider.com - May 1 at 7:15 PMAmarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focusfinance.yahoo.com - May 1 at 2:14 PMAmarin Plc (AMRN) Q1 2024 Earnings Call Transcriptfool.com - May 1 at 2:14 PMAMRN Stock Earnings: Amarin Corp Beats EPS, Misses Revenue for Q1 2024investorplace.com - May 1 at 1:02 PMAmarin Reports First Quarter 2024 Business Update and Financial Resultsglobenewswire.com - May 1 at 7:00 AMHere's what Wall Street expects from Amarin's earnings reportmarkets.businessinsider.com - April 30 at 9:50 PMAmarin Q1 2024 Earnings Previewmsn.com - April 30 at 2:08 PMAmarin Co. plc (NASDAQ:AMRN) Short Interest Updatemarketbeat.com - April 28 at 1:11 PMAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Eventfinance.yahoo.com - April 24 at 4:47 PMAmarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Eventglobenewswire.com - April 24 at 2:00 PMAmarin Announces Results of Annual General Meeting of Shareholdersglobenewswire.com - April 22 at 8:00 AMAmarin Corporation: Small Signs Of Recovery May Not Be Enoughseekingalpha.com - April 18 at 12:18 AMAmarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024globenewswire.com - April 15 at 8:00 AMAmarin Corporation plc: New REDUCE-IT Analyses Show VASCEPA/VAZKEPA (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroupsfinanznachrichten.de - April 8 at 8:22 AMAmarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24globenewswire.com - April 8 at 8:00 AMNew REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroupsglobenewswire.com - April 6 at 3:30 PMWhy Amarin Stock Was Rocketing Higher on Wednesdayfool.com - April 3 at 4:13 PMAmarin: IP Protection For VAZKEPA In Europe Now Extended Into 2039 - Quick Factsmarkets.businessinsider.com - April 3 at 9:58 AMAmarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europeglobenewswire.com - April 3 at 8:00 AMResearch Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expofinance.yahoo.com - March 25 at 7:36 PMResearch Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expoglobenewswire.com - March 25 at 8:00 AMAMRN Apr 2024 3.000 callfinance.yahoo.com - March 16 at 10:26 AMAMRN Apr 2024 1.500 putfinance.yahoo.com - March 8 at 12:20 AMAMRN May 2024 1.000 callfinance.yahoo.com - March 7 at 7:20 PMFY2024 EPS Estimates for Amarin Co. plc (NASDAQ:AMRN) Boosted by Analystmarketbeat.com - March 7 at 7:37 AMAMRN Mar 2024 0.500 callfinance.yahoo.com - March 6 at 7:34 PMAmarin Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 5 at 10:01 AM13D Management LLC Sells 2,579,723 Shares of Amarin Co. plc (NASDAQ:AMRN)marketbeat.com - March 3 at 12:27 PMAmarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 11:19 PMEarnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecastsfinance.yahoo.com - March 2 at 1:17 PMAmarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 1 at 9:19 AMAmarin’s Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansionmarkets.businessinsider.com - February 29 at 7:41 PMAmarin Plc (AMRN) Q4 2023 Earnings Call Transcriptfool.com - February 29 at 7:41 PMWhy Is Amarin Stock Trading Lower After Q4 Earnings?msn.com - February 29 at 2:23 PMAmarin Corporation plc: Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - February 29 at 9:22 AMAmarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61Mmsn.com - February 29 at 9:22 AMAmarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competitionfinance.yahoo.com - February 29 at 9:22 AMAmarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - February 29 at 7:00 AMAmarin Q4 2023 Earnings Previewmsn.com - February 28 at 2:51 PMAmarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024finance.yahoo.com - February 15 at 10:23 AMQ1 2025 EPS Estimates for Amarin Co. plc (NASDAQ:AMRN) Lifted by Zacks Researchmarketbeat.com - February 15 at 8:44 AMAmarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024globenewswire.com - February 15 at 8:00 AMFY2023 Earnings Estimate for Amarin Co. plc (NASDAQ:AMRN) Issued By Leerink Partnrsmarketbeat.com - February 8 at 7:06 AMFY2027 Earnings Forecast for Amarin Co. plc Issued By Leerink Partnrs (NASDAQ:AMRN)marketbeat.com - February 7 at 9:09 AM Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AMRN Media Mentions By Week AMRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRN News Sentiment▼0.200.43▲Average Medical News Sentiment AMRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRN Articles This Week▼82▲AMRN Articles Average Week Get Amarin News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lexicon Pharmaceuticals News Revance Therapeutics News Mereo BioPharma Group News Esperion Therapeutics News Mersana Therapeutics News Biomea Fusion News Corbus Pharmaceuticals News Nature's Sunshine Products News ADC Therapeutics News Harrow Health News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRN) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amarin Co. plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
